CDKN2A and cancer: Classically, genetic mutations in oncogenes were taken as the main cancer sponsor, coupled with genetically tamped down actions by cancer suppressors, such as p53, INK4, PTEN, VHL, APC, BRCA2, and pRb (Fig. 3).